1
Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.
Condition(s):Multiple MyelomaLast Updated:September 2, 2022Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:September 2, 2022Not yet recruiting
Condition(s):Leukemia, Lymphocytic, Chronic, B-CellLast Updated:March 28, 2024Not yet recruiting
Condition(s):Plasmablastic LymphomaLast Updated:October 11, 2023Recruiting
Condition(s):DLBCLLast Updated:December 28, 2023Recruiting
Condition(s):Crohn DiseaseLast Updated:November 9, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:January 3, 2019Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.